상세검색
최근 검색어 전체 삭제
다국어입력
즐겨찾기0
학술저널

Genetics of Mitochondrial Myopathies

  • 8
111625.jpg

Mitochondrion is an intracellular organelle with its own genome. Its function in cellular metabolism is indispensable that mitochondrial dysfunction gives rise to multisystemic failure. The manifestation is most prominent with tissues of high energy demand such as muscle and nerve. Mitochondrial myopathies occur not only by mutations in mitochondrial genome, but also by defects in nuclear genes or secondarily by toxic insult on mitochondrial replication. Currently curative treatment modality does not exist and symptomatic treatment remains mainstay. Administration of L-arginine holds great promise according to the recent reports. Advances in mitochondrial RNA import might enable a new therapeutic strategy.

Abstract

Introduction

Mitochondrial myopathiesby mitochondrial genomic mutation

Mitochondrial myopathy by nuclear genomic mutation

Mitochondrial myopathy not by primary genetic defect

Skeletal muscle biopsy in mitochondrial myopathy

MELAS: mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes

MERRF: myoclonic epilepsy with RRF

PEO: progressive external ophthalmoplegia

Therapeutic approaches

References

(0)

(0)

로딩중